Laden…
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
L-DOPA is a biochemical precursor of dopamine that is used in the brain to increase dopamine levels. It is primarily employed in the treatment of Parkinson's disease to compensate for dopaminergic deficits. The substance acts indirectly by increasing dopamine availability and thus affects dopaminergic receptors. Side effects may include motor dysfunctions and neuropsychiatric effects. L-DOPA is not a classic stimulant but shows stimulating effects through dopamine enhancement.
Class
Aminosäuren
Pharmacological context
Mechanism
L-DOPA wird im Gehirn in Dopamin umgewandelt, was zu einer Erhöhung der...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Designations
IUPAC: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propionic acid
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Synapedia Evidence
Effects & Pharmacology translation in progress
English prose is being expanded. The German version currently has more detail.
Reported range 300 mg
Total duration 4–6 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 100 mg |
| Reported | 300 mg |
| Strong | 600 mg |
Oral
Onset
30–60 minutes
Peak
1–2 hours
Total duration
4–6 hours
After effects
1–2 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Nebenwirkungen sind Übelkeit, Schwindel und dyskinetische Bewegungen.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.